Finance

Lists
ALPMY:OTCMKTS
Astellas Pharma ADR Representing 1 Ord Shs
၁၄.၃၉ US$
၀.၀၀%
(၀.၀၀) 1D
အောက် ၁၃, GMT-၄ ၁၅:၅၉:၅၄  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALPMY...
Mkt. cap
ဋေ ၄.၀၉ သိန်း
Avg. vol.
၁.၀၄ သိန်း
Volume
၁၄.၀၀
52-wk high
၁၇.၃၅ US$
52-wk low
၁၀.၀၅ US$
Beta
၀.၁၃
Shares outstanding
၁၈၀.၉၇ ဋေ
No. of employees
၁ သောင်း
Mkt. cap
ဋေ ၄.၀၉ သိန်း
Avg. vol.
၁.၀၄ သိန်း
Volume
၁၄.၀၀
52-wk high
၁၇.၃၅ US$
52-wk low
၁၀.၀၅ US$
Beta
၀.၁၃
Shares outstanding
၁၈၀.၉၇ ဋေ
No. of employees
၁ သောင်း
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၁၆ နာရီ
Will Fast Track Status Change Astellas Pharma Stock Narrative
Profile
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
About Astellas Pharma ADR Representing 1 Ord Shs
CEONaoki Okamura
Employees၁.၄၁ သောင်း
Founded၂၀၀၅ ဧ ၁
HeadquartersChuo City, တိုကျိုမြို့, ဂျပန်
Sector-
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၅.၂၄ သ
ဋေ ၅.၅၅ သ
ဋေ ၅.၃၈ သ
ဋေ ၆.၄၁ သ
Cost of goods sold
ဋေ ၁.၀၆ သ
ဋေ ၁.၀၄ သ
ဋေ ၉.၃၇ ထ
ဋေ ၁.၂၃ သ
Cost of revenue
ဋေ ၁.၀၆ သ
ဋေ ၁.၀၄ သ
ဋေ ၉.၃၇ ထ
ဋေ ၁.၂၃ သ
Research and development expenses
ဋေ ၇.၁၆ ထ
ဋေ ၈.၅၈ ထ
ဋေ ၉.၅၉ ထ
ဋေ ၈.၁၇ ထ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
ဋေ ၂.၀၇ သ
ဋေ ၂.၂၈ သ
ဋေ ၂.၃၅ သ
ဋေ ၂.၁၅ သ
Operating expense
ဋေ ၃.၂၆ သ
ဋေ ၃.၅၉ သ
ဋေ ၃.၃၆ သ
ဋေ ၃.၃၃ သ
Total operating expenses
ဋေ ၄.၃၁ သ
ဋေ ၄.၆၃ သ
ဋေ ၄.၃၀ သ
ဋေ ၄.၅၆ သ
Operating income
ဋေ ၉.၂၉ ထ
ဋေ ၉.၁၆ ထ
ဋေ ၁.၀၈ သ
ဋေ ၁.၈၅ သ
Other non operating income
-
၁.၅၀ သန်း
-၂၄.၁၀ ကုဋေ
၁.၀၀ သန်း
EBT including unusual items
ဋေ ၁.၀၄ သ
ဋေ ၉.၁၀ ထ
ဋေ ၄.၈၀ ထ
ဋေ ၁.၈၇ သ
EBT excluding unusual items
ဋေ ၉.၂၄ ထ
ဋေ ၉.၀၈ ထ
ဋေ ၁.၁၄ သ
ဋေ ၁.၈၇ သ
Income tax expense
ဋေ ၂.၅၀ ထ
ဋေ ၁.၉၀ ထ
၄၄၀.၈၀ ဋေ
ဋေ ၄.၄၈ ထ
Effective tax rate
၂၃.၉၇%
၂၀.၉၀%
၉.၁၈%
၂၄.၀၀%
Other operating expenses
ဋေ ၁.၄၇ ထ
၉၇၂.၃၅ ဋေ
-ဋေ ၂.၉၉ ထ
၃၈.၈၀ ကုဋေ
Net income
ဋေ ၇.၉၂ ထ
ဋေ ၇.၂၀ ထ
ဋေ ၄.၃၅ ထ
ဋေ ၁.၄၂ သ
Net profit margin
၁၅.၁၁%
၁၂.၉၇%
၈.၀၉%
၂၂.၁၃%
Earnings per share
-
-
-
-
Interest and investment income
၂၁၅.၂၀ ဋေ
၂၁၀.၃၅ ဋေ
၁၂၉.၀၀ ဋေ
၅၁၃.၀၀ ဋေ
Interest expense
-၂၆၉.၃၀ ဋေ
-၂၇၄.၀၅ ဋေ
-
-၃၁၂.၁၀ ဋေ
Net interest expenses
-၅၄.၁၀ ကုဋေ
-၆၃.၇၀ ကုဋေ
၁၂၉.၀၀ ဋေ
၂၀၀.၉၀ ဋေ
Depreciation and amortization charges
-ဋေ ၃.၂၈ ထ
-
ဋေ ၃.၅၈ ထ
-
EBITDA
ဋေ ၁.၄၀ သ
ဋေ ၁.၄၁ သ
ဋေ ၁.၅၈ သ
ဋေ ၂.၃၅ သ
Gain or loss from assets sale
ဋေ ၁.၆၄ ထ
-
ဋေ ၃.၁၅ ထ
-
AI content may include mistakes. Learn more
Google အက်ပ်များ